The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
. Survival of persons with and without HIV infection in Denmark, 1995-2005.
Abstract
BACKGROUND: The expected survival of HIV-infected patients is of major public health interest. OBJECTIVE: To estimate survival time and age-specific mortality rates of an HIV-infected population compared with that of the general population. DESIGN: Population-based cohort study. SETTING: All HIV-infected persons receiving care in Denmark from 1995 to 2005. PATIENTS: Each member of the nationwide Danish HIV Cohort Study was matched with as many as 99 persons from the general population according to sex, date of birth, and municipality of residence. MEASUREMENTS: The authors computed Kaplan-Meier life tables with age as the time scale to estimate survival from age 25 years. Patients with HIV infection and corresponding persons from the general population were observed from the date of the patient's HIV diagnosis until death, emigration, or 1 May 2005. RESULTS: 3990 HIV-infected patients and 379,872 persons from the general population were included in the study, yielding 22,744 (median, 5.8 y/person) and 2,689,287 (median, 8.4 years/person) person-years of observation. Three percent of participants were lost to follow-up. From age 25 years, the median survival was 19.9 years (95% CI, 18.5 to 21.3) among patients with HIV infection and 51.1 years (CI, 50.9 to 51.5) among the general population. For HIV-infected patients, survival increased to 32.5 years (CI, 29.4 to 34.7) during the 2000 to 2005 period. In the subgroup that excluded persons with known hepatitis C coinfection (16%), median survival was 38.9 years (CI, 35.4 to 40.1) during this same period. The relative mortality rates for patients with HIV infection compared with those for the general population decreased with increasing age, whereas the excess mortality rate increased with increasing age. LIMITATIONS: The observed mortality rates are assumed to apply beyond the current maximum observation time of 10 years. CONCLUSIONS: The estimated median survival is more than 35 years for a young person diagnosed with HIV infection in the late highly active antiretroviral therapy era. However, an ongoing effort is still needed to further reduce mortality rates for these persons compared with the general population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is an emerging consensus in the scientific community that HIV infection hastens the process of aging and that illnesses that appear typically in the elderly are highly frequent among HIV-infected individuals, even in those with therapy-induced suppression of the virus below detection limits [59,60].”
From T-cell aging in rheumatoid arthritis (2014) · cites this paper as [59]
In the citing paper
“When compared to behaviorally and demographically similar HIV-uninfected individuals, people with HIV infection, even those receiving effective ART with suppression of virus to levels below typical detection limits, experience excess morbidity and mortality (3,4).”
Citations
Cites
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. D., Knysz, B., Dietrich, M., Phillips, A. N., & Lundgren, J. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13802-0 · Cited by 1,241
When an Entire Country Is a Cohort
Frank, L. (2000) · Science · doi:10.1126/science.287.5462.2398 · Cited by 865
Galván, F. H., Bing, E. G., Fleishman, J. A., London, A. S., Caetano, R., Burnam, M. A., Longshore, D. L., Morton, S. C., Orlando, M., & Shapiro, M. F. (2002) · Journal of Studies on Alcohol · doi:10.15288/jsa.2002.63.179 · Cited by 438
Laing, S. P., Swerdlow, A. J., Slater, S. D., Botha, J. L., Burden, A. C., Waugh, N. R., Smith, A. W. M., Hill, R. D., Bingley, P. J., Patterson, C. C., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00075.x · Cited by 427
Savès, M., Chêne, G., Ducimetière, P., Leport, C., Moal, G. L., Amouyel, P., Arveiler, D., Ruidavets, J., Reynes, J., Bingham, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375844 · Cited by 399
Cigarette Smoking and the Desire to Quit Among Individuals Living with HIV
Mamary, E. M., Bahrs, D., & Martinez, S. A. (2002) · AIDS Patient Care and STDs · doi:10.1089/108729102753429389 · Cited by 155
UK CHIC Study Group The UK Collaborative Group on HIV Drug Resistance (2005) · AIDS · doi:10.1097/01.aids.0000162337.58557.3d · Cited by 149
Estimating the proportion of patients infected with HIV who will die of comorbid diseases
Braithwaite, R. S., Justice, A. C., Chang, C. H., Fusco, J. S., Raffanti, S. R., Wong, J. B., & Roberts, M. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.034 · Cited by 136
Lundgren, J. D., Mocroft, A., Gatell, J. M., Ledergerber, B., Monforte, A. D., Hermans, P., Goebel, F., Blaxhult, A., Kirk, O., Phillips, A. N., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338267 · Cited by 129
Press, N., TYNDALL, M. W., Wood, E., Hogg, R. S., & Montaner, J. S. G. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200212153-00005 · Cited by 116
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population
Jaggy, C., von Overbeck, J., Ledergerber, B., Schwarz, C., Egger, M., Rickenbach, M., Furrer, H., Telenti, A., Battegay, M., Flepp, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14307-3 · Cited by 114
Low mortality in HIV-infected patients starting highly active antiretroviral therapy
Jensen‐Fangel, S., Pedersen, L. H., Pedersen, C., Larsen, C. S., Tauris, P., Møller, A., Sørensen, H. T., & Obel, N. (2004) · AIDS · doi:10.1097/00002030-200401020-00011 · Cited by 102
Self-citationKeiser, O., Taffé, P., Zwahlen, M., Battegay, M., Bernasconi, E., Weber, R. K., & Rickenbach, M. (2004) · AIDS · doi:10.1097/00002030-200409030-00013 · Cited by 88
Demographics of HIV-1 infection in Denmark: Results from the Danish HIV Cohort Study
Lohse, N., Hansen, A. E., Jensen‐Fangel, S., Kronborg, G., Kvinesdal, B. B., Pedersen, C., Larsen, C. S., Møller, A., Willumsen, L., & Obel, N. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510031692 · Cited by 80
Self-citationA nosocomial sapovirus-associated outbreak of gastroenteritis in adults
Johansson, P. J., Bergentoft, K., Larsson, P. A., Magnusson, G., Widell, A., Thorhagen, M., & Hedlund, K. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410020974 · Cited by 78
van Sighem, A., Danner, S. A., Ghani, A. C., Gras, L. A., Anderson, R. M., & de Wolf, F. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000165911.97085.d0 · Cited by 61
Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individuals
Lohse, N., Obel, N., Kronborg, G., Laursen, A. L., Pedersen, C., Larsen, C. S., Kvinesdal, B. B., Sørensen, H. T., & Gerstoft, J. (2005) · AIDS · doi:10.1097/01.aids.0000168976.51843.9f · Cited by 41
Self-citationJensen‐Fangel, S., Pedersen, C., Larsen, C. S., Tauris, P., Møller, A., & Obel, N. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655401317074590 · Cited by 20
Self-citationLohse, N., Ladefoged, K., Pedersen, L. H., Jensen‐Fangel, S., Sørensen, H. T., & Obel, N. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410020974a · Cited by 11
Self-citationCommentary: Death in the era of potent antiretroviral therapy: shifting causes, new challenges
Zwahlen, M. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh402 · Cited by 9
[Epidemiology of hepatitis C].
Pb, C. (1998) · PubMed · Cited by 9
Research works printed but not linked: 1
- Christensen PB, 1998, Ugeskr Laeger, 160, 3529
Cited by
Sorted by citations
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613
Vandenbroucke, J. P., Elm, E. V., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010-w1 · Cited by 3,543
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.07.014 · Cited by 2,969
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2007) · Epidemiology · doi:10.1097/ede.0b013e3181577511 · Cited by 2,779
Antiretroviral Treatment of Adult HIV Infection
Thompson, M., Aberg, J. A., Hoy, J., Telenti, A., Benson, C., Cahn, P. E., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,493
Metadata
- Authors
- Lohse, N., Hansen, A.-B. E., Pedersen, G., Kronborg, G., Gerstoft, J., Sørensen, H. T., Væth, M., & Obel, N.
- Affiliations
- Boston University (US)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2007-01-16
- Volume
- 146
- Issue
- 2
- Pages
- 87-95
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1967548282
- Cited by
- 748
- References
- 21
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 15 · 2023: 9 · 2022: 14 · 2021: 17 · 2020: 19 · 2019: 15 · 2018: 34 · 2017: 32 · 2016: 44 · 2015: 54 · 2014: 62 · 2013: 75 · 2012: 73
- FWCI
- 39.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- HIV infection, survival, mortality, age-specific mortality, excess mortality, hepatitis C coinfection, highly active antiretroviral therapy, HIV cohort, Denmark, life tables, HIV treatment outcomes
- MeSH terms
- Adult, Cause of Death, Denmark, Female, Hepatitis C, Humans, Life Expectancy, Male, Middle Aged, Prospective Studies, HIV Infections, Survival Rate, Case-Control Studies, Antiretroviral Therapy, Highly Active
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review